Regeneron Pharmaceuticals, Inc. (REGN)
FDA Applications
Note: This list only includes applications that have been responded to by the FDA.
| Application | Product Name | Active Ingredient | Form | Strength | Status | ||
|---|---|---|---|---|---|---|---|
| BLA761355 - REGENERON PHARMACEUTICALS | |||||||
| EYLEA HD | AFLIBERCEPT | INJECTABLE;INJECTION | 8MG(0.07ML;114.3MG/ML) | Prescription | |||
| BLA761339 - REGENERON PHARMACEUTICALS | |||||||
| VEOPOZ | POZELIMAB-BBFG | INJECTABLE;INJECTION | 400MG/2ML(200MG/ML) | Prescription | |||
| BLA761181 - REGENERON PHARMACEUTICALS | |||||||
| EVKEEZA | EVINACUMAB-DGNB | SOLUTION; INJECTION | 345MG/2.3ML | Prescription | |||
| EVKEEZA | EVINACUMAB-DGNB | SOLUTION; INJECTION | 1200MG/8ML | Prescription | |||
| BLA761169 - REGENERON PHARMACEUTICALS | |||||||
| INMAZEB | ATOLTIVIMAB; ODESIVIMAB; MAFTIVIMAB | SOLUTION; INJECTION | 16.7MG/1ML | Prescription | |||
| BLA761097 - REGENERON PHARMACEUTICALS | |||||||
| LIBTAYO | CEMIPLIMAB-RWLC | INJECTABLE;INTRAVENOUS | 350MG | Prescription | |||
| BLA761055 - REGENERON PHARMACEUTICALS | |||||||
| DUPIXENT | DUPILUMAB | INJECTABLE; INJECTION | 150MG/ML | Prescription | |||
| BLA125559 - REGENERON PHARMACEUTICALS | |||||||
| PRALUENT | ALIROCUMAB | INJECTABLE;INJECTION | 75MG | Prescription | |||
| PRALUENT | ALIROCUMAB | INJECTABLE;INJECTION | 150MG | Prescription | |||
| BLA125387 - REGENERON PHARMACEUTICALS | |||||||
| EYLEA | AFLIBERCEPT | INJECTABLE; INJECTION | 40MG/ML | Prescription | |||